Informing Treatment Decisions in Psoriatic Arthritis: The Value of Network Meta-Analyses
Executive Summary
Network meta-analysis is a technique used for comparing several interventions simultaneously. NMAs are often used by regulators, health technology assessment agencies, and medical guideline committees. However, there is also a very important place for them in treatment decisions.
You may also be interested in...
The Immortal Humira? In Huge Test For US Biosimilar Policy, Brand May Still Have Edge
First Humira biosimilar launches raise worries about holes in US health system that may let the brand product continue to dominate. If Humira biosimilars can’t get a strong foothold, reform to biosimilar policy for medicines reimbursed through the pharmacy benefit may be necessary if the US wants to rely on these products to bring down the cost of brand biologics.
House Health Subcommittee Chair Prioritizes Affordability, Innovation, Ending COVID PHE
Kentucky Republican Brett Guthrie is strong proponent of health care affordability and innovation in pharmaceuticals and medical devices. He’s also monitoring FDA’s response to drug shortages and infant formula shortages.
US Dietary Supplement Industry In 2023: Little New Expected In NDI Notification Enforcement
Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight concludes series here reporting on supplement sector’s outlook for FDA potentially resolving its protracted struggle with NDI notification requirement.